Table 1.
Psy-IPV study population: inclusion/exclusion criteria, data collection dates, and regions
| Consortium | Inclusion criteria | Exclusion criteria | Data collection dates | Regions |
|---|---|---|---|---|
| CNICS | ≥18 | Unable or unwilling to complete questionnaire | 2016-2018 | AL, CA, MA, NC, OH, WA |
| PLWH | ||||
| In routine HIV care | ||||
| English or Spanish-speaking | ||||
| PACTO (STTR) | ≥18 | Unable to consent due to cognitive or developmental impairment | 2013-2014 | Puerto Rico |
| PLWH | ||||
| Able to communicate in English | ||||
| Report any drug (excluding nicotine) and/or heavy alcohol use within the past 12 months | ||||
| RETAIN (STTR) | ≥18 | Unable to consent due to cognitive or developmental impairment | 2013-2015 | FL, GA |
| PLWH | ||||
| Cocaine/crack use in past 3 months | ||||
| AIDS-defining illness OR CD4 <350 AND a viral load >1000 copies/mL in the medical record in the past 3 months, OR Have a CD4 count <350 cells/uL AND a viral load >200 copies/mL as obtained via baseline blood draw, OR Clinical profile indicative of a persistently detectable HIV viral load (>200 copies/mL) | Currently receiving patient navigator services for HIV care or substance use treatment |